Open Access
Feature Article

Insomnia treatment. Improved access to effective nondrug options

ALEXANDER SWEETMAN, NICOLE LOVATO, JENNY HAYCOCK, Leon Lack

Figures

© AMENIC181/ISTOCKPHOTO.COM model used for illustrative purposes only
© AMENIC181/ISTOCKPHOTO.COM model used for illustrative purposes only
Dr Sweetman and Dr Lovato are joint first authors.
Dr Sweetman is a Research Associate at the Adelaide Institute for Sleep Health and the National Centre for Sleep Health Services Research, Flinders University, Adelaide. Dr Lovato is a Senior Research Fellow at the Adelaide Institute for Sleep Health and the National Centre for Sleep Health Services Research, Flinders University, Adelaide. Ms Haycock is a PhD Candidate at the Adelaide Institute for Sleep Health and the National Centre for Sleep Health Services Research, Flinders University, Adelaide. Professor Lack is an Emeritus Professor in the College of Education, Psychology and Social Work and the National Centre for Sleep Health Services Research, Flinders University, Adelaide, SA.

 

Advertisement

References

1.    American Academy of Sleep Medicine. International Classification of Sleep Disorders (ICSD-3), Diagnostic and coding manual. 3rd ed. Westchester, Ill: American Academy of Sleep Medicine; 2014.
2.    Adams RJ, Appleton SL, Taylor AW, et al. Sleep health of Australian adults in 2016: results of the 2016 Sleep Health Foundation national survey. Sleep Health 2017; 3: 35-42.
3.    Leger D, Massuel MA, Metlaine A; SISYPHE Study Group. Professional correlates of insomnia. Sleep 2006; 29: 171-178.
4.    Reynolds AC, Appleton SL, Gill TK, et al. Sickness absenteeism is associated with sleep problems independent of sleep disorders: results of the 2016 Sleep Health Foundation national survey. Sleep Health 2017; 3: 357-361.
5.    Hollingworth SA, Siskind DJ. Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiol Drug Saf 2010; 19: 280-288.
6.    Miller CB, Valenti L, Harrison CM, et al. Time trends in the family physician management of insomnia: the Australian experience (2000–2015). J Clin Sleep Med 2017; 13: 785-790.
7.    Morin AK, Jarvis CI, Lynch AM. Therapeutic options for sleep-maintenance and sleep-onset insomnia. Pharmacotherapy 2007; 27: 89-110.
8.    Royal Australian College of General Practitioners. Prescribing drugs of dependence in general practice, Part B: Benzodiazepines. Melbourne: RACGP; 2015.
9.    Carney CE, Buysse DJ, Ancoli-Israel S, et al. The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep 2012; 35: 287-302.
10.    Espie CA, Kyle SD, Hames P, Gardani M, Fleming L, Cape J. The Sleep Condition Indicator: a clinical screening tool to evaluate insomnia disorder. BMJ Open 2014; 4: e004183.
11.    Bastien CH, Vallières A, Morin CM. Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med 2001; 2: 297-307.
12.    Gradisar M, Lack L, Harris J, et al. The Flinders Fatigue Scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomnia. J Clin Sleep Med 2007; 3: 722-728.
13.    Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 2002; 32: 509-515.
14.    Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092-1097.
15.    Chai-Coetzer CL, Antic NA, Rowland LS, et al. A simplified model of screening questionnaire and home monitoring for obstructive sleep apnoea in primary care. Thorax 2011; 66: 213-219.
16.    Sweetman A, Lack LC, Catcheside PG, et al. Developing a successful treatment for co-morbid insomnia and sleep apnoea. Sleep Med Rev 2017; 33: 28-38.
17.    Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991; 14: 540-545.
18.    Bonnet MH, Arand DL. Hyperarousal and insomnia. Sleep Med Rev 1997; 1(2): 97-108.
19.    Riemann D, Spiegelhalder K, Feige B, et al. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 2010; 14: 19-31.
20.    Sweetman A, McEvoy RD, Smith S, et al. The effect of cognitive and  behavioral therapy for insomnia on week-to-week changes in sleepiness and sleep parameters in patients with comorbid insomnia and sleep apnea: a randomized controlled trial. Sleep 2020; 43: zsaa002.
21.    Sweetman A, Lack LC, Lambert S, Gradisar M, Harris J. Does comorbid obstructive sleep apnea impair the effectiveness of cognitive and behavioral therapy for insomnia? Sleep Med 2017; 39: 38-46.
22.    Blom K, Jernelöv S, Rück C, Lindefors N, Kaldo V. Three-year follow-up comparing cognitive behavioral therapy for depression to cognitive behavioral therapy for insomnia, for patients with both diagnoses. Sleep 2017; 40: zsx108.
23.    Wu JQ, Appleman ER, Salazar RD, Ong JC. Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis. JAMA Intern Med 2015; 175: 1461-1472.
24.    Lovato N, Lack L, Wright H, Kennaway DJ. Evaluation of a brief treatment program of cognitive behavior therapy for insomnia in older adults. Sleep 2014; 37: 117-126.
25.    Espie CA, MacMahon KMA, Kelly H-L, et al. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep 2007; 30: 574-584.
26.    Lack L. Treating insomnia: alternatives to drug therapies. Med Today  2016; 17(10): 41-48.
27.    Bruck D, Dolan CL, Lack LC. Beliefs about the ‘shape’ and continuity of healthy sleep as a function of age. J Psychosom Res 2015; 78: 39-44.
28.    Chung K-F, Lee C-T, Yeung W-F, Chan M-S, Chung EW-Y, Lin W-L. Sleep hygiene education as a treatment of insomnia: a systematic review and meta-analysis. Fam Pract 2018; 35: 365-375.
29.    Sweetman A, Zwar N, Grivell N, Lovato N, Lack L. A step-by-step model for a brief behavioural treatment for insomnia in Australian general practice. Aust J Gen Pract 2020. In press.
30.    Buysse DJ, Germain A, Moul DE, et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med 2011; 171: 887-895.
31.    Troxel WM, Germain A, Buysse DJ. Clinical management of insomnia with brief behavioral treatment (BBTI). Behav Sleep Med 2012; 10: 266-279.
32.    Espie CA, Kyle SD, Williams C, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 2012; 35: 769-781.
33.    Ritterband LM, Thorndike FP, Gonder-Frederick LA, et al. Efficacy of an Internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiatry 2009; 66: 692-698.
34.    Zachariae R, Lyby MS, Ritterband LM, O’Toole MS. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia – a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev 2016; 30: 1-10.
35.    Forsell E, Jernelöv S, Blom K, et al. Proof of concept for an adaptive treatment strategy to prevent failures in internet-delivered CBT: a single-blind randomized clinical trial with insomnia patients. Am J Psychiatry 2019; 176: 315-323.
36.    Hoon E, Grivell N, Haycock J, et al. Managing sleep disorders: a qualitative study exploring current practices, knowledge and attitudes of general practitioners [abstract P058]. J Sleep Res 2019; 28 Suppl 1: 29.
37.    Sweetman A, Lack L, Catcheside PG, et al. Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: a randomized clinical trial. Sleep 2019; 42: zsz178.
38.    Charles J, Harrison C, Britt H. Insomnia. Aust Fam Physician 2009; 38: 283.
39.    Glass J, Lanctôt KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331: 1169.
40.    Ashton H. Protracted withdrawal syndromes from benzodiazepines. J Subst Abuse Treat 1991; 8: 19-28.
41.    Kripke DF. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Res 2016; 5: 918.
42.    Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, Vallières A. Randomized clinical trial of supervised training and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry 2004; 161: 332-342.
43.    Takaesu Y, Utsumi T, Okajima I, et al. Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: a systematic review and meta-analysis. Sleep Med Rev 2019; 48: 101214.
44.    Sweetman A, Putland S, Lack L, McEvoy D, et al. The effect of cognitive behavioural therapy for insomnia on sedative-hypnotic use: a narrative review. Sleep Med Rev 2020. In press.